Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mucin-1 | 9 | 2017 | 543 | 1.430 |
Why?
|
Cancer Vaccines | 6 | 2022 | 1021 | 0.850 |
Why?
|
Leukemia, Myeloid, Acute | 9 | 2021 | 3497 | 0.760 |
Why?
|
Dendritic Cells | 8 | 2023 | 2723 | 0.370 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 694 | 0.350 |
Why?
|
Azacitidine | 3 | 2019 | 347 | 0.310 |
Why?
|
T-Lymphocytes | 8 | 2021 | 10163 | 0.300 |
Why?
|
Lymphocyte Activation | 5 | 2022 | 5519 | 0.280 |
Why?
|
Peptides | 3 | 2015 | 4392 | 0.260 |
Why?
|
Neoplastic Stem Cells | 1 | 2013 | 1376 | 0.260 |
Why?
|
Hematologic Neoplasms | 1 | 2016 | 1820 | 0.240 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2012 | 1379 | 0.240 |
Why?
|
Multiple Myeloma | 5 | 2023 | 5169 | 0.240 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2017 | 206 | 0.240 |
Why?
|
Interferon-gamma | 3 | 2017 | 3199 | 0.230 |
Why?
|
Forkhead Transcription Factors | 2 | 2012 | 1613 | 0.220 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2017 | 651 | 0.220 |
Why?
|
Antigens, Neoplasm | 3 | 2021 | 1983 | 0.220 |
Why?
|
Lymphocyte Culture Test, Mixed | 3 | 2012 | 517 | 0.210 |
Why?
|
Graft vs Host Disease | 3 | 2023 | 2951 | 0.200 |
Why?
|
Immune Tolerance | 2 | 2012 | 2257 | 0.200 |
Why?
|
Cell Proliferation | 7 | 2020 | 10472 | 0.190 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2016 | 2986 | 0.190 |
Why?
|
Oncogene Proteins | 2 | 2016 | 749 | 0.190 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2020 | 1377 | 0.170 |
Why?
|
MicroRNAs | 4 | 2020 | 3731 | 0.170 |
Why?
|
Cell Communication | 3 | 2017 | 1619 | 0.160 |
Why?
|
Oligonucleotides, Antisense | 1 | 2020 | 433 | 0.160 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2019 | 233 | 0.150 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2018 | 150 | 0.150 |
Why?
|
Oligonucleotides | 1 | 2020 | 572 | 0.150 |
Why?
|
Antineoplastic Agents | 5 | 2017 | 13655 | 0.140 |
Why?
|
Vaccination | 2 | 2021 | 3256 | 0.140 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2023 | 5425 | 0.140 |
Why?
|
Tretinoin | 1 | 2019 | 516 | 0.140 |
Why?
|
Drug Synergism | 2 | 2016 | 1791 | 0.130 |
Why?
|
Antigens, CD34 | 2 | 2016 | 657 | 0.130 |
Why?
|
Isoantigens | 2 | 2017 | 567 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 11472 | 0.120 |
Why?
|
Remission Induction | 2 | 2017 | 2384 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2019 | 4438 | 0.120 |
Why?
|
Flow Cytometry | 3 | 2015 | 5975 | 0.120 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 2 | 2012 | 42 | 0.120 |
Why?
|
Immunoenzyme Techniques | 2 | 2015 | 1799 | 0.120 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2019 | 870 | 0.110 |
Why?
|
Immunotherapy, Adoptive | 2 | 2021 | 1255 | 0.110 |
Why?
|
Herpesvirus 4, Human | 1 | 2018 | 1040 | 0.110 |
Why?
|
Antigens, CD20 | 1 | 2013 | 198 | 0.110 |
Why?
|
Cell Line, Tumor | 9 | 2020 | 16665 | 0.110 |
Why?
|
Mice, Inbred NOD | 2 | 2015 | 1875 | 0.110 |
Why?
|
Apoptosis | 4 | 2020 | 9715 | 0.100 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2012 | 310 | 0.100 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2018 | 569 | 0.100 |
Why?
|
Mice, SCID | 2 | 2015 | 2715 | 0.100 |
Why?
|
Stromal Cells | 1 | 2017 | 1353 | 0.100 |
Why?
|
Immunity, Cellular | 2 | 2019 | 1606 | 0.100 |
Why?
|
Viral Proteins | 1 | 2018 | 1899 | 0.090 |
Why?
|
Mice | 10 | 2022 | 81045 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 491 | 0.090 |
Why?
|
Tumor Microenvironment | 2 | 2019 | 3564 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2020 | 8425 | 0.090 |
Why?
|
Animals | 12 | 2022 | 168561 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4751 | 0.090 |
Why?
|
Blotting, Western | 2 | 2015 | 5180 | 0.080 |
Why?
|
Coculture Techniques | 3 | 2017 | 1341 | 0.080 |
Why?
|
Oxidative Stress | 2 | 2017 | 3081 | 0.080 |
Why?
|
Tumor Cells, Cultured | 4 | 2019 | 6313 | 0.080 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2009 | 200 | 0.080 |
Why?
|
Immunophenotyping | 1 | 2013 | 1866 | 0.080 |
Why?
|
Lymphocyte Subsets | 1 | 2009 | 315 | 0.080 |
Why?
|
Leukocytes, Mononuclear | 2 | 2017 | 1835 | 0.080 |
Why?
|
T-Lymphocyte Subsets | 2 | 2012 | 1837 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2638 | 0.070 |
Why?
|
Thalidomide | 1 | 2012 | 888 | 0.070 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2009 | 595 | 0.070 |
Why?
|
T-Box Domain Proteins | 1 | 2009 | 471 | 0.070 |
Why?
|
Bone Marrow | 1 | 2017 | 2941 | 0.070 |
Why?
|
Interleukin-2 | 2 | 2012 | 1887 | 0.070 |
Why?
|
Humans | 27 | 2023 | 742088 | 0.070 |
Why?
|
Cell Separation | 1 | 2012 | 1749 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 3557 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4147 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2723 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 5163 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5249 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 2013 | 9274 | 0.060 |
Why?
|
Interleukin-10 | 1 | 2009 | 1200 | 0.060 |
Why?
|
Stem Cell Transplantation | 1 | 2012 | 1618 | 0.060 |
Why?
|
Antigens, CD | 2 | 2016 | 4024 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2015 | 13029 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2009 | 2006 | 0.050 |
Why?
|
Cytokines | 2 | 2017 | 7317 | 0.050 |
Why?
|
Signal Transduction | 4 | 2017 | 23387 | 0.050 |
Why?
|
Immunotherapy | 1 | 2016 | 4414 | 0.050 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2023 | 902 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2017 | 11470 | 0.050 |
Why?
|
Gene Silencing | 2 | 2017 | 1538 | 0.040 |
Why?
|
Antigens, CD19 | 1 | 2021 | 379 | 0.040 |
Why?
|
U937 Cells | 1 | 2019 | 268 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2017 | 2077 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2023 | 2123 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 931 | 0.040 |
Why?
|
Mitoxantrone | 1 | 2017 | 149 | 0.040 |
Why?
|
Cross-Priming | 1 | 2017 | 82 | 0.040 |
Why?
|
Perforin | 1 | 2017 | 168 | 0.040 |
Why?
|
Virus Activation | 1 | 2019 | 319 | 0.040 |
Why?
|
Transplantation, Homologous | 2 | 2018 | 4771 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2017 | 286 | 0.040 |
Why?
|
Dexamethasone | 1 | 2023 | 1949 | 0.030 |
Why?
|
Retroviridae | 1 | 2019 | 914 | 0.030 |
Why?
|
Etoposide | 1 | 2017 | 637 | 0.030 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2016 | 107 | 0.030 |
Why?
|
Cytarabine | 1 | 2017 | 684 | 0.030 |
Why?
|
Chronic Disease | 2 | 2023 | 9144 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5662 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2017 | 891 | 0.030 |
Why?
|
Ribonuclease III | 1 | 2017 | 275 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 2016 | 275 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2019 | 2085 | 0.030 |
Why?
|
NADP | 1 | 2015 | 225 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2017 | 1368 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1274 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2017 | 527 | 0.030 |
Why?
|
DNA Methylation | 2 | 2019 | 4282 | 0.030 |
Why?
|
Immunomodulation | 1 | 2017 | 540 | 0.030 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 430 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1567 | 0.030 |
Why?
|
Glutathione | 1 | 2015 | 586 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 874 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2021 | 2524 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 974 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2187 | 0.030 |
Why?
|
Female | 6 | 2020 | 379592 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2016 | 1097 | 0.020 |
Why?
|
Cadherins | 1 | 2016 | 906 | 0.020 |
Why?
|
Down-Regulation | 1 | 2019 | 3001 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 987 | 0.020 |
Why?
|
Immune System | 1 | 2016 | 804 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2017 | 1269 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2019 | 21821 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1643 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2017 | 1782 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15244 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18006 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1158 | 0.020 |
Why?
|
Male | 4 | 2018 | 349538 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 1683 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2107 | 0.020 |
Why?
|
Adult | 4 | 2018 | 213712 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4211 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 1 | 2017 | 2038 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2013 | 3701 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3504 | 0.020 |
Why?
|
Lymphoma, B-Cell | 1 | 2013 | 930 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2012 | 57683 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9735 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5872 | 0.020 |
Why?
|
Middle Aged | 3 | 2018 | 213127 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2906 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5867 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10248 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6382 | 0.020 |
Why?
|
Computational Biology | 1 | 2016 | 3518 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1889 | 0.010 |
Why?
|
Gene Expression | 1 | 2017 | 7790 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2130 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4664 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29010 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 21719 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2012 | 19223 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 40450 | 0.010 |
Why?
|
Aged | 2 | 2018 | 162944 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 29717 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 56350 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 62966 | 0.010 |
Why?
|
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(48)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_